Eliana Lacerda

Eliana Lacerda MD PhD MSc is a Clinical Assistant Professor and part of the Cure ME team at the London School of Hygiene and Tropical Medicine, London, UK. She oversees the UK ME/CFS Biobank, from recruitment of participants through to release of samples.

She has a medical background, with training in public health and occupational health.

EUROMENE
Dr. Lacerda is the Vice Chair of EUROMENE, a European Union not-for-profit research organization committed to tackling the cause and treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, and was a founder member of the network.

Learn more

 * LSHTM bio

Notable studies

 * 2018, Functional Status and Well-Being in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Compared with People with Multiple Sclerosis and Healthy Controls (Full Text)
 * 2017, How have selection bias and disease misclassification undermined the validity of myalgic encephalomyelitis/chronic fatigue syndrome studies? (Full Text)
 * 2017, The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENE (Full Text)
 * 2017, Editorial - Using a participatory approach to develop and implement the UK ME/CFS Biobank
 * 2014, Considerations in establishing a post-mortem brain and tissue bank for the study of myalgic encephalomyelitis/chronic fatigue syndrome: A proposed protocol (Full Text)
 * 2011, A Disease Register for ME/CFS: Report of a Pilot Study (Full Text)
 * 2011, Social support needs for equity in health and social care: a thematic analysis of experiences of people with chronic fatigue syndrome/myalgic encephalomyelitis (Full Text)
 * 2011, Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care (Full Text)
 * 2011, The functional status and well being of people with myalgic encephalomyelitis/chronic fatigue syndrome and their carers (Full Text)
 * 2010, Exploring the feasibility of establishing a disease-specific post-mortem tissue bank in the UK: a case study in ME/CFS (Abstract)